申请人:Ono Pharmaceutical Co., Ltd.
公开号:US08975409B2
公开(公告)日:2015-03-10
The compound represented by the formula (I-1):
wherein all the symbols have the same meanings as described in the specification, has two cyclic groups, particularly phenoxy groups at specific substitution positions and thus has high human S1P2 antagonistic activity. The compound may therefore be used as a therapeutic agent for S1P2-mediated diseases such as diseases resulting from vascular constriction, fibrosis and respiratory diseases.
化合物的化学式为(I-1):其中所有符号的含义与说明书中描述的相同,具有两个环状基团,特别是在特定的取代位置上有苯氧基团,因此具有高人类S1P2拮抗活性。因此,该化合物可用作S1P2介导疾病的治疗剂,例如由血管收缩、纤维化和呼吸系统疾病引起的疾病。